Revenue
2024
2025
2026
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Price—Loading quote
Net income
2024
2025
2026
Free cash flow
2024
2025
2026
Total cash / debt
CashTotal debt
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Revenue | $95.1M | $59.8M | $27.8M |
| Gross profit | $48.9M | $24.2M | $362,000 |
| Research & development | $19.5M | $15.7M | $15.5M |
| Operating expenses | $183.6M | $130.6M | $85.4M |
| Operating income | −$134.7M | −$106.4M | −$85.1M |
| EBITDAderived | −$126.0M | −$98.4M | −$73.5M |
| Net income | −$131.6M | −$113.8M | −$94.1M |
| Basic EPSper diluted share | -$2.43 | -$5.13 | -$5.07 |
| Diluted EPSper diluted share | -$2.43 | -$5.13 | -$5.07 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026Form 4 · 10b5-1 | Webster Brian DanielSee Remarks | SellCommon Shares | 15.0K | $20.81 | $312.1K | 395.5K |
| May 15, 2026Form 4 · 10b5-1 | Webster Brian DanielSee Remarks | SellCommon Shares | 6.8K | $21.46 | $146.9K | 334.8K |
| May 15, 2026Form 4 · 10b5-1 | Webster Brian DanielSee Remarks | SellCommon Shares | 8.2K | $20.53 | $167.4K | 341.6K |
| Apr 15, 2026Form 4 · 10b5-1 | Webster Brian DanielSee Remarks | SellCommon Shares | 15.0K | $20.04 | $300.6K | 349.8K |
| Mar 26, 2026Form 4 | COHEN RAYMOND WDirector | BuyCommon Shares | 10.0K | $19.98 | $199.8K | 50.9K |